Introduction There is uncertainty surrounding the diagnosis, prevalence, phenotype,
duration and treatment of Long COVID. This study aims to (A) describe the clinical …

Background: We describe post-COVID symptomatology in a non-hospitalised, national
sample of 11–17-year-old children and young people (CYP) with PCR-confirmed SARS …

Background Little is known about the prevalence and natural trajectory of post-COVID
symptoms in young people, despite very high numbers of young people having acute …

Background We describe post-COVID symptomatology in a non-hospitalised, national
sample of adolescents aged 11–17 years with PCR-confirmed SARS-CoV-2 infection …

Background Despite high numbers of children and young people (CYP) having acute
COVID, there has been no prospective follow-up of CYP to establish the pattern of health …

Summary Background In children, SARS-CoV-2 infection is usually asymptomatic or causes
a mild illness of short duration. Persistent illness has been reported; however, its prevalence …

Background To update and internally validate a model to predict children and young people
(CYP) most likely to experience long COVID (ie at least one impairing symptom) 3 months …

Background Adults and children can develop post-Covid-19 condition (PCC)(also referred to
as Long Covid). However, existing evidence is scarce, partly due to a lack of a standardised …

Background Many adolescents have been affected by the COVID-19 pandemic either
directly by being infected with the virus or indirectly by lockdowns and restrictions …

Background After the acute phase of SARS-CoV-2 infection, children can develop long
COVID symptoms. We aimed to investigate the prevalence of long-lasting symptoms, the …